YORK, Pa., May 19, 2011 /PRNewswire/ — Unilife Corporation
(“Unilife” or the “Company”) (NASDAQ:
UNIS; ASX: UNS) today announced that it will be presenting at
the 2011 UBS Global Specialty Pharmaceuticals Conference in London.
Dr. Ramin Mojdeh, Executive Vice-President and Chief Operating
Officer of Unilife, is scheduled to present at 11:00 a.m. British
Summer Time (6:00 a.m. U.S. EDT) on Wednesday, May 25, 2011.
The conference presentation will be broadcast over the Internet
as a “live” listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm.
An archive of the event will also be available for those unable to
About Unilife CorporationUnilife Corporation (NASDAQ:
UNIS / ASX: UNS) is a U.S. based developer, manufacturer and
supplier of advanced drug delivery systems with state-of-the-art
facilities in Pennsylvania. Established in 2002, Unilife works with
pharmaceutical and biotechnology companies seeking innovative
devices for use with their parenteral drugs and vaccines. Unilife
has developed a broad, differentiated proprietary portfolio of its
own injectable drug delivery products, including the
Unifill® and Unitract® product lines
of safety syringes with automatic, operator controlled needle
retraction. Unifill represents the world’s first prefilled syringe
technology integrating safety within the primary drug container.
The products are ideally positioned to help pharmaceutical
companies maximize the lifecycle of their injectable drugs and
enhance patient care. Unifill syringes, together with other devices
that are part of the Unilife technology platform, can either be
supplied to pharmaceutical customers ready for use, or customized
to address the specific requirements